Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose colchicine for arterial stiffness in patients with diabetes mellitus
TCTR20211110002Phase 4Enrolling by invitation
- Sponsor
- Faculty of Medicine, Prince of Songkhla University
- Start
- Aug 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in arteriosclerosis, type 2 diabetes mellitus (T2DM), sponsored by Faculty of Medicine, Prince of Songkhla University. Started Aug 2021; status: enrolling by invitation.
02
Drugs
colchicine
03
Conditions
arteriosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20211110002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211110002.